Tag Archives: Parkinson’s

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes Print this page SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50 mg capsules as an… Read More »

Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease

Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease. The portal enables… Read More »

Fingernail Sensor and Artificial Intelligence for Monitoring Parkinson’s, Other Diseases

December 21st, 2018 Editors Diagnostics, Neurology, Rehab Grip strength, as well as walking speed and gait length, can be indicators of a person’s physical and mental health. A variety of conditions and treatments can be monitored from the grip strength, but such measurements are typically only performed infrequently at the doctor’s office. IBM Research has… Read More »